$13M sweet spot round size
Most of their 53 investments are in rounds between $7.5M and $22M
1996
Vividion Therapeutics. Inc. raised $82M on April 30, 2019
Investors: Nextech Invest, Casdin Capital, LLC, Celgene, Mirae Asset MAPS Global Investments Co., Ltd, Versant Ventures, ARCH Venture Partners and Cardinal Partners (CP)
Cureatr raised $3M on June 18, 2018
Investors: Windham Venture Partners, JMI Equity, Partnership for New York City and Cardinal Partners (CP)
Prealize Health, formerly Cardinal Analytx Solutions raised $6.1M on September 27, 2017
Investors: Cardinal Partners (CP)
Vividion Therapeutics. Inc. raised $50M on February 2, 2017
Investors: Versant Ventures, ARCH Venture Partners and Cardinal Partners (CP)
Vividion Therapeutics. Inc. raised $3.5M on April 11, 2016
Investors: Cardinal Partners (CP)
lifeIMAGE raised $5.1M on September 24, 2015
Investors: van Galen, Cambia Health Solutions, LRVHealth, Blue Cross Blue Shield of Massachusetts and Cardinal Partners (CP)
Ivenix, Inc. raised $42M on September 1, 2015
Investors: Easterly Capital, F-Prime Capital Partners, SCP Vitalife and Cardinal Partners (CP)
Cureatr raised $13M on June 25, 2015
Investors: Windham Venture Partners, JMI Equity and Cardinal Partners (CP)
lifeIMAGE raised $18M on May 28, 2015
Investors: van Galen, Partners HealthCare, Cambia Health Solutions, LRVHealth, MassVentures and Cardinal Partners (CP)
aTyr Pharma raised $76M on March 31, 2015
Investors: Sofinnova Ventures, Russia technology fund, Domain Associates, Federated Investors, T. Rowe Price and Cardinal Partners (CP)